(Q35033505)

5 August 2017

1 reference

title

A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation (English)

1 reference

5 August 2017

1 reference

1 reference

D A Fitzmaurice

1

1 reference

5 August 2017

P Kesteven

2

1 reference

5 August 2017

K M Gee

3

1 reference

5 August 2017

E T Murray

4

1 reference

5 August 2017

R McManus

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Journal of Clinical Pathology

5 August 2017

published in

1 reference

5 August 2017

volume

56

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

48-51

1 reference

Does the Birmingham model of oral anticoagulation management in primary care work outside trial conditions?

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Dosing practices of physicians for anticoagulation with warfarin during inpatient rehabilitation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Improved therapeutic safety of oral anticoagulant therapy in Germany: the Saarland model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Assessment of mental ability in elderly anticoagulated patients: its reduction is associated with a less satisfactory quality of treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Evaluation of a primary care anticoagulant clinic. Reporting of results should be standardised

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

A method to determine the optimal intensity of oral anticoagulant therapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Can warfarin randomized trials be reproduced in 'real life'? Adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

The effect of self-monitoring the INR on quality of anticoagulation and quality of life.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769863

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

25 October 2018

1 reference

12 December 2020

Evaluation of a nurse specialist anticoagulant service

1 reference

12 December 2020

Anticoagulant control in the first three months after mechanical heart valve replacement

1 reference

12 December 2020

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients

1 reference

12 December 2020

A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.56.1.48

1 reference

5 August 2017

1 reference

5 August 2017

1 reference